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ABSTRACT
Juvenile granulosa cell tumor (JGCT), classified as 
a sex cord-stromal tumor, is a rare neoplasm. This is 
an instructive case report of JGCT accompanied by 
augmented interleukin (IL)-6 secretion. A 13-year-
old girl with prolonged fever and delayed puberty was 
diagnosed with JGCT of the left ovary based on an 
imaging study and pathological investigation. Although 
it was not clear whether IL-6 was secreted from the tu-
mor cells, her serum level of IL-6 was very high. After 
tumorectomy, the patient’s symptoms immediately 
disappeared, her IL-6 level decreased, and she entered 
puberty. Therefore, augmented IL-6 secretion produc-
tion induced by tumors should be considered a potential 
cause of prolonged fever and/or delayed puberty.
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Granulosa cell tumor (GCT) is a type of ovarian neo-
plasm categorized as a sex cord-stromal tumor. GCT 
is very common in adults, particularly in peri- and 
postmenopausal females1; however, juvenile GCT is 
extremely rare, with only 5% of GCT cases occurring 
during childhood.2 GCT is classified as borderline 
malignant tumor. A majority of juvenile GCT (JGCT) 
cases have localized lesions and take a benign course3–5; 
however, a few JGCT cases have been reported to be 
invasive and fatal despite intensive chemotherapy.3–5
Common symptoms of JGCT include an abdomi-
nal mass and/or pain and precocious puberty due to 
elevated estrogen secretion.3–5 Herein, we report a case 
of JGCT accompanied by augmented interleukin (IL)-6 
secretion, resulting in continuous fever, general fatigue, 
and delayed puberty.
PATIENT REPORT
A 13-year-old girl visited a hospital due to low-grade 
fever and general fatigue for 5 months. Later, she was 
referred to Tottori University Hospital because she was 
diagnosed with an abdominal tumor through computed 
tomography (CT). Her body temperature was 38.6 °C, 
and physical examination revealed a mass without 
tenderness in her lower abdomen. She had facial and 
conjunctival pallor. Her breasts and pubic hair were in 
the prepuberal state (Tanner developmental stage 1).
The results of a blood test revealed remarkably aug-
mented inflammatory reaction; that is, the white blood 
cells and platelet count increased to 16,000/μL and 
723,000/μL, respectively, and microcytic hypochromic 
anemia was detected. The erythrocyte sedimentation 
rate was 140 mm/h. Blood levels of C-reactive protein 
(CRP: 18.7 mg/dL), serum amyloid A (SAA: 1750 μg/
mL, normal < 8 μg/mL), fibrinogen (732 mg/dL), fer-
ritin (429 ng/mL), haptoglobin (665 mg/dL), and immu-
noglobulin G (2,982 mg/dL) were elevated. Moreover, 
the serum inflammatory cytokine levels of soluble IL-2 
receptor and IL-6 were elevated to 1,465 U/mL (normal, 
145–519) and 348 pg/mL (normal, < 4), respectively. In 
contrast, the levels of serum albumin (1.8 g/dL), iron (12 
μg/dL), and unsaturated iron binding capacity (192 μg/
dL) decreased. Serum cancer antigen (CA)-125, a tumor 
marker, was elevated (6,020 U/mL, normal < 35). Serum 
alpha-fetoprotein, beta-human chorionic gonadotropin, 
CA19-9, and carcinoembryonic antigen were within 
normal limits. Serum estradiol, luteinizing hormone 
(LH), and follicle stimulating hormone (FSH) were not 
elevated (14.5 pg/mL, < 0.1 mIU/mL, and 0.33 mIU/
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mL, respectively). This data was in accordance with the 
prepuberal pattern.
CT and magnetic resonance imaging (MRI) 
examination revealed that the tumor was located in the 
left side of the pelvic cavity (Figs. 1A–C). No metastatic 
lesions were detected.
The patient underwent laparoscopic left salpingo-
oophorectomy 6 days after admission. The tumor 
was excised by piecemeal resection. The gross image 
is presented in Figs. 2A and 2B. Histologically, the 
tumor was mainly composed of sheet-like growth of 
neoplastic cells with abundant eosinophilic cytoplasm 
and round nuclei (Figs. 2C and 2D). A pseudopapillary 
pattern and follicles containing eosinophilic secretions 
were focally observed. Tumor cells lacked the nuclear 
grooves characteristic of adult granulosa cell tumors. 
Immunohistochemically, the tumor was focally positive 
for inhibin-α (Fig. 2E), CD56, CD99 and cytokeratin 
AE1/AE3, and negative for calretinin, PAX8, CD10, 
estrogen receptor, progesterone receptor, chromogranin 
A, synaptophysin, c-kit, and podoplanin/D2-40. The 
Ki-67 index was approximately 3%. These findings 
were consistent with a diagnosis of juvenile granulosa 
cell tumor.
To investigate the mechanism underlying the 
elevation of serum IL-6 level, we evaluated tumoral 
IL-6 expression through immunohistochemistry. A 
rabbit polyclonal anti-IL-6 antibody (ab6672, Abcam, 
Cambridge, UK) was used as a primary antibody at 
dilution of 1:400. Antigen retrieval was performed by 
Fig. 1. Imaging of the tumor. A, B, and C are plane CT, MRI T1 weighted image (WI), and T2WI, respectively (red arrows). The tumor 
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Fig. 2. Gross image and histology of the ovarian tumor. (A) The gross image of the tumor before (A, white arrows) and after (B) the 
resection. The tumor surface was smooth and white while whole. The cut surface was solid and yellow in color. (C) The tumor is mainly 
composed of sheet-like growth of neoplastic cells, focally showing a pseudopapillary pattern (top left) and follicle formation (bottom 
right) (hematoxylin and eosin stain). (D) High-power view of the tumor (hematoxylin and eosin stain). (E) Immunohistochemistry for 
inhibin-α. (F) Immunohistochemistry for IL-6 showing positive staining in a subset of tumor cells as well as non-neoplastic stromal 
tissue (white asterisk). Note IL-6-positive immune cells from human tonsil used as positive controls (inset). Bars; (C) 100 μm, (D–F) 20 
μm.
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treating the section with proteinase K (Code: S3020, 
Agilent, Santa Clara, CA) according to the manufac-
turer’s instructions. Immune cells from the human ton-
sil were used as positive controls.6 We observed weak 
cytoplasmic staining for IL-6 in a subset of neoplastic 
cells of the ovarian tumor (Fig. 2F); however, the stain-
ing was also observed in non-neoplastic stromal tissue 
within the tumor, probably reflecting an increased IL-6 
level in extracellular interstitial fluid.
After the surgery, the patient’s body temperature 
rapidly lowered to normal range, and the fever did not 
recur. The serum IL-6 level decreased by 1.6 pg/mL 
10 days after the surgery. Other elevated inflammatory 
indices and tumor marker levels immediately returned 
to normal. The levels of estradiol, LH, and FSH were 
low (< 10 pg/mL, 0.18 mIU/mL, and 3.66 mIU/mL, 
respectively) 3 days after the operation. One month 
after the operation, although the level of estradiol was 
still low (< 10 pg/mL), LH and FSH were elevated to 
33.19 and 68.49 mIU/mL, respectively. The patient had 
her first menstrual period 2 months post operation. Six 
months after the operation, values of estradiol, LH, and 
FSH reached the puberal pattern (23.85 pg/mL, 3.92 
mIU/mL, and 4.81 mIU/mL, respectively). One year 
after the operation, her breasts and pubic hair reached 
stage 4 and stage 3 of the Tanner developmental stages, 
respectively. No recurrence of GCT has been observed 
for 3 years after the operation, and she has presented a 
normal progression of puberty.
DISCUSSION
In this case, an ovarian GCT patient with prolonged 
fever was assessed. Although the major symptoms of 
GCT include abdominal distention, palpable tumor, or 
gonadotropin-independent precocious puberty, a few 
cases also presented with fever in a previous report.4 
As the serum IL-6 level of our patient was consider-
ably high, we assumed that the IL-6 produced by GCT 
caused prolonged fever.
Certain IL-6 producing tumors such as atrial myx-
oma,7 mesothelioma,8 pheochromocytoma,9 paragan-
glioma,10 bladder cancer,11 and renal cell cancer12 have 
been reported. IL-6 is one of the major inflammatory 
cytokines produced by various kinds of cells including 
lymphocytes, monocytes, macrophages, neutrophils, 
fibroblasts, and endothelial cells.13 Serum IL-6 induces 
the production of acute-phase proteins such as CRP, 
SAA, fibrinogen, and haptoglobin, whereas it reduces 
the production of albumin.14 Moreover, IL-6 promotes 
IL-2 receptor expression and produces hepcidin, which 
causes anemia by increasing iron storage and inhibiting 
intestinal iron absorption.14 Conceivably, augmented 
IL-6 secretion would have triggered the inflammatory 
sequence reactions in this case. Both the symptoms and 
the laboratory data were in line with this scenario. We 
performed immunohistochemical analysis for IL-6 in 
order to clarify whether it was produced by the tumor 
cells. However, it was not possible to determine whether 
the positive immunohistochemical staining results indi-
cated true expression of IL-6 in the ovarian tumor cells 
or simply represented IL-6 in the interstitial fluid at the 
tumor cell surface. Additionally, we could not investi-
gate gene expression of IL-6 in the GCT cells because 
neither fresh nor frozen samples could be obtained. 
Accordingly, we could not confirm IL-6 production by 
analyzing gene expression or by using flow cytometry.
Despite the age of 13 years, secondary sexual 
characteristics were not observed in the patient before 
the operation. Although the detailed mechanism is 
unclear, inflammatory cytokines are known to have 
adverse effects on the nutritional state and to inhibit 
gonadotropin releasing hormone (GnRH) secretion in 
chronic inflammatory diseases such as inflammatory 
bowel disease (IBD).15 According to an experiment 
using an IBD mouse model, one of the possible mecha-
nisms underlying delayed puberty in the inflammatory 
setting involves a decreased level of leptin, a hormone 
responsible for the secretion of GnRH.16 We, therefore, 
speculate that the pubertal delay in this case was due 
to elevated IL-6 level associated with the GCT because 
the patient experienced pubertal progression in response 
to the normalization of IL-6 and acute phase proteins 
levels in the serum.
We reported a GCT case with elevated serum 
IL-6 level showing atypical symptoms of prolonged 
low-grade fever and delayed puberty. It is possible 
that juvenile GCT promotes IL-6 secretion, and this 
should be included in the differential diagnosis list for 
prolonged fever. Imaging tests such as CT and MRI 
should be made routinely for early detection. This case 
demonstrated that massive IL-6 secretion can suppress 
gonadal function and result in the delay of puberty.
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